Cancer Prevention and Control Clinical Trials Planning Grant Program
National Institutes of Health (NIH)
Up to $225,000 per year for a maximum of three years without a clinical trial.
Up to $600,000 in direct costs over three years if a pilot/feasibility clinical trial is included.
Facilitate well-planned clinical trials across the cancer prevention and control spectrum.
Improve prevention, health behaviors, screening, early detection, and supportive care for cancer survivors.
Researchers in cancer prevention and control.
Cancer patients and survivors.
National Cancer Institute (NCI)
Cooperative Agreement
Recurring funding opportunity with multiple application deadlines.
Higher Education Institutions
Public/State Controlled Institutions of Higher Education
Private Institutions of Higher Education
Nonprofits (with or without 501(c)(3) status)
For-Profit Organizations
Small Businesses
Local, State, County, City Governments
Indian/Native American Tribal Governments
Federal Agencies
Foreign Organizations
Must have an eRA Commons account for Program Directors/Principal Investigators.
Organizations from the U.S. and foreign organizations are eligible.
Cancer prevention and interception.
Cancer screening and early detection.
Behavioral research in cancer prevention and control.
Data critical for planning future clinical trials.
Improved trial design and rigor.
Expertise in clinical trial design and implementation.
Up to $225,000 per year without a clinical trial.
Up to $600,000 in direct costs over three years with a pilot/feasibility clinical trial.
Open Date: January 25, 2025.
Multiple application deadlines through 2027.
Must comply with NIH Grants Policy Statement.
Application forms via Grants.gov or NIH ASSIST.
Milestone Plan and Future Clinical Trial Description.